UC Santa Barbara Policy 1640
Policies
Issuing Unit: Academic Affairs Date: September 1, 1975
USE OF CONTROLLED SUBSTANCES (THE RESEARCH OF THE NATURE AND THE EFFECTS
OF MARIJUANA AND HALLUCINOGENIC DRUGS)
I. REFERENCES:
A. 21 United States Code, 801 et seq. (Public Law 91-513).
B. California Health and Safety Code, Sections 11655.5 and
11655.6.
C. University of California Business and Finance Bulletin, BUS-50,
Acquisition and Use of Narcotics and Dangerous Drugs.
D. California Health and Safety Code, Article 210 as amended by
Statutes 1969, Chapter 1618 No. 1.
E. Vice President McCorkle's delegation of authority to
Chancellors and Laboratory Directors, Registration and
Acquisition of Narcotics and Dangerous Drugs, dated August 14,
1972.
F. Chancellor Cheadle's delegation of authority to UCSB Materiel
Manager, December 14, 1972.
G. UCSB Research Circular No. 4-73, Policy on the Research of the
Nature and the Effects of Marijuana and Hallucinogenic Drugs.
II. POLICY:
The Controlled Substances Act, effective May 1, 1971, placed the
control of narcotics and dangerous drugs under the jurisdiction of
the U.S. Department of Justice, Drug Enforcement Administration.
A. Schedules of Controlled Substances:
Five schedules of controlled substances have been defined as
follows (the composition of these schedules may change by
amendment to the Controlled Substance Act):
1. Schedule I Substances. Drugs in this schedule are those
having a high potential for abuse, having no currently
accepted medical use in the United States, or a lack of
accepted safety. Some examples are: heroin, marijuana,
LSD, peyote, mescaline, psilocybin, tetrahydrocannabinols,
morphine methylsulfonate, and nicocodein.
2. Schedule II Substances. The drugs in this schedule have a
high potential for abuse, a currently accepted medical use
in the United States, and their use may lead to severe
psychological or physical dependence. Most of Schedule II
Substances have been known in the past as Class A Narcotic
Drugs; some examples are: opium, morphine, codeine,
dihydromorphinone (Dilaudid), methadone (Dolophine),
pentopon, meperidine (Demerol), cocaine, oxycodone
(Percodan). Also included in this Schedule is any compound
which contains in any form the substance of
methamphetamines as an injectable liquid.
3. Schedule III Substances. The drugs in this schedule have
an abuse potential less than those listed in Schedules I
and II, and include those drugs formerly known as Class B
Narcotics, and non-narcotic drugs such as: glutethimide
(Doriden), phenmetrazine (Preludin), methyprylon
(Noludar), methylphenidate (Ritalin), nalorphine, and
barbiturates (except phenobarbital, methylphenobarbital,
and barbital). Paregoric is now listed in this schedule,
as well as amphetamines and methamphetamines (except an
injectable liquid).
4. Schedule IV Substances. The drugs in this schedule have an
abuse potential less than those listed in Schedule III and
includes drugs such as: barbital, phenobarbital,
methylphenobarbital, chloral hydrate, ethchlorvynol
(Placidyl), ethinamate (Valmid), meprobamate (Equanil,
Miltown).
5. Schedule V Substances. The drugs in this schedule have an
abuse potential less than those listed in Schedule IV, and
consist of those preparations formerly known as Exempt
Narcotics, with the exception of paregoric (Camphorated
Tincture of Opium). Paregoric is now listed as a Schedule
III Controlled Substance.
B. Registration:
1. Registration Classifications:
Of the registration classifications established by DEA and
State Law, the following apply to this campus:
a. Teaching Institution; to be used for instruction
purposes only, using Controlled Substances listed in
Schedules II. through V.
b. Hospital Clinic; authority to dispense and to conduct
institutional activities, using Controlled Substances
listed in Schedules II. through V.
c. Research; to conduct research with narcotic and
non-narcotic Controlled Substances listed in
Schedules II through V.
d. Research; to conduct research with a Controlled
Substance listed in Schedule I.
e. Chemical Analysis; (distinct from research); to
conduct chemical analyses with Controlled Substances
listed in any Schedule.
2. Extent of Registration
a. For each of the above registration classifications
(paragraph III.B.1.) one registration covers all such
activities on campus, except for classification
III.B.1.d.
b. Classification III.B.1.d. requires a separate
registration for each research project.
c. If an operation remote from the campus required
Controlled Substances, a separate registration is
necessary for each type of activity involved.
3. Filing Application for Registration
The campus Materiel Manager has been designated as the
individual authorized to apply for campus and research
registration and to procure Controlled Substances, and to
coordinate the paperwork necessary to secure approval of
the proposed activity from the Research Advisory Panel.
Inquiries, including those pertaining to registration,
procedures for procurement, security, required records and
inventories, and authorized disposal of Controlled Sub
stances, should be directed to the campus Office of
Material Manager.
C. Research Proposals:
If a proposed research project involves the use of any Schedule
I controlled substance, or human research utilizing any
Schedule II controlled substance except those listed under
stimulants, the DEA requires that a notice of approval of the
proposed activity issued by the Research Advisory Panel be
submitted along with the request for registration. The UCSB
Contracts and Grants Office will be unable to process a
proposal for mailing to the funding agency unless approval of
the Panel is submitted along with the proposed application.
(See paragraph II.B.3 above.)
1. The Research Advisory Panel
The Research Advisory Panel consists of representatives
of: the State Department of Public Health, the State
Department of Mental Hygiene, the Chairman of the
Interagency Council on Drug Abuse, the California State
Board of Pharmacy, the Attorney General's Office, and a
private university selected annually by the Governor.
D. Report of Drug Abuse Project:
1. The California Health and Safety Code establishes The
Regents of the University of California as the information
exchange for drug abuse research and service projects. In
turn, this responsibility has been delegated to the UCSF
Department of Pharmacology and is referred to as the Drug
Abuse Information Program (DAIP).
2. This program does not alter the general campus procedures
for submitting proposals, but the statute does require the
reporting of such projects promptly upon award, regardless
of funding source; see Attachment A for the reporting form
(UCSB/CGO Form No. 17).
III. ATTACHMENT:
A. Report of Drug Abuse Project.
Please direct questions about these policies to Meta.Clow@vcadmin.ucsb.edu. For questions or comments regarding the format of the above information, please contact webcontact@ucsbuxa.ucsb.edu.
Return to the UCSB home page.
Last Modified By: EBH, 7/09/98